Finance

Beta
Lists
688506:SHA
Sichuan Biokin Pharmaceutical Co Ltd
CN¥212.29
-0.29%
(-0.61) 1D
Jun 5, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688506...
Open
CN¥217.00
High
CN¥221.01
Low
CN¥210.13
Mkt. cap
87.65B
Avg. vol.
2.17M
Volume
1.68M
52-wk high
CN¥414.02
52-wk low
CN¥200.10
EPS
-CN¥3.16
No. of employees
3K
Open
CN¥217.00
High
CN¥221.01
Low
CN¥210.13
Mkt. cap
87.65B
Avg. vol.
2.17M
Volume
1.68M
52-wk high
CN¥414.02
52-wk low
CN¥200.10
EPS
-CN¥3.16
No. of employees
3K
News stories
From sources across the web
Profile
Sichuan Biokin Pharmaceutical Co., Ltd. is a publicly listed Chinese biopharmaceutical company that is headquartered in Chengdu, Sichuan. Wikipedia
About Sichuan Biokin Pharmaceutical Co Ltd
CEO-
Employees3.2K
FoundedAug 23, 1996
Headquarters-
SectorPharmaceutical industry
Websiteen.baili-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
103.76M
1.89B
454.22M
94.59M
Cost of goods sold
65.53M
43.74M
115.66M
43.37M
Cost of revenue
65.53M
43.74M
115.66M
43.37M
Research and development expenses
543.72M
733.75M
741.34M
694.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
123.67M
144.15M
169.94M
126.35M
Operating expense
670.71M
862.71M
926.05M
813.01M
Total operating expenses
736.24M
906.45M
1.04B
856.38M
Operating income
-632.48M
988.25M
-587.49M
-761.79M
Other non operating income
8.83M
-68.11M
68.05M
-142.74M
EBT including unusual items
-589.09M
942.32M
-535.84M
-776.15M
EBT excluding unusual items
-612.76M
977.50M
-586.93M
-841.61M
Income tax expense
-2.57M
318.88M
23.26M
-1.59M
Effective tax rate
0.44%
33.84%
-4.34%
0.21%
Other operating expenses
4.41M
-15.12M
14.55M
-7.43M
Net income
-586.52M
623.44M
-559.10M
-774.56M
Net profit margin
-565.28%
32.90%
-123.09%
-818.89%
Earnings per share
-
-
-
-
Interest and investment income
57.17M
54.03M
56.43M
89.48M
Interest expense
-18.50M
-24.43M
-26.18M
-26.56M
Net interest expenses
38.66M
29.60M
30.26M
62.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
-614.13M
1.01B
-567.21M
-741.51M
Gain or loss from assets sale
-1.06K
1.06K
-1.06K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer